LEXINGTON, Mass.--(BUSINESS WIRE)--EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that it is scheduled to present at the Natixis Bleichroeder Second Annual Hidden Gems Conference on Monday, October 13, 2008. Elkan Gamzu, Ph.D., interim chief executive officer of EPIX, is scheduled to discuss the company’s business strategy and corporate overview at 10:30 a.m. (ET) at the Waldorf-Astoria Hotel in New York City.
